---
title: "Here’s How Much You Would Have Made Owning Axsome Therapeutics Stock In The Last 5 Years"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296143429.md"
description: "Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past five years with an annualized return of 58.59%. A $100 investment made five years ago would now be worth $1,086.24, based on a current stock price of $216.06 and a market capitalization of $11.32 billion. The article highlights the significant impact of compounded returns on cash growth over time."
datetime: "2026-08-17T20:15:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296143429.md)
  - [en](https://longbridge.com/en/news/296143429.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296143429.md)
generator: "portal-rs"
---

# Here’s How Much You Would Have Made Owning Axsome Therapeutics Stock In The Last 5 Years

Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 5 years by 46.84% on an annualized basis producing an average annual return of 58.59%. Currently, Axsome Therapeutics has a market capitalization of $11.32 billion.

**Buying $100 In AXSM:** If an investor had bought $100 of AXSM stock 5 years ago, it would be worth **$1,086.24** today based on a price of $216.06 for AXSM at the time of writing.

### Axsome Therapeutics’s Performance Over Last 5 Years

![comp_fig](https://imageproxy.pbkrs.com/https://cdn.benzinga.com/files/images/story/2026/08/17/b467c6f04e266cbded665023c57d4db0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

*This article was generated by Benzinga's automated content engine and reviewed by an editor.*

### Related Stocks

- [AXSM.US](https://longbridge.com/en/quote/AXSM.US.md)

## Related News & Research

- [AXSM: AUVELITY's growth accelerates with new indications and strong pipeline progress, supported by solid financials](https://longbridge.com/en/news/298507457.md)
- [Canada Pension Plan Investment Board Invests $55.17 Million in Axsome Therapeutics, Inc. $AXSM](https://longbridge.com/en/news/297285876.md)
- [Great Lakes Advisors LLC Invests $1.65 Million in Axsome Therapeutics, Inc. $AXSM](https://longbridge.com/en/news/296676631.md)
- [Axsome Therapeutics to present at H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/297773934.md)
- [Axsome COO Mark Jacobson sells 10,000 shares for $2.09 million](https://longbridge.com/en/news/297966428.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**